In mice, metformin increased the number of tumor infiltrating CD8+ T cells, and the combination of metformin and a tumor vaccine improved the multifunctionality of the vaccine-induced CD8+ tumor infiltrating lymphocytes (TIL) (138). The gene discussed is CD8A; the disease is neoplasm.